Crossref
FDA approves first treatment for smoldering multiple myeloma
Cancer · 01.03.2026 · 132 (5)
DOI: 10.1002/cncr.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 04.03.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lawrence, L. (2026). FDA approves first treatment for smoldering multiple myeloma. Cancer, 132(5). https://doi.org/10.1002/cncr.70276
Vancouver
Lawrence L. FDA approves first treatment for smoldering multiple myeloma. Cancer. 2026;132(5). doi:10.1002/cncr.70276
BibTeX
@article{Lawrence2026,
author = {Lawrence, Leah},
title = {FDA approves first treatment for smoldering multiple myeloma},
journal = {Cancer},
year = {2026},
volume = {132},
number = {5},
doi = {10.1002/cncr.70276}
}
EUVIMED